Ibrutinib-Associated Leukocytoclastic Vasculitis in a Patient with Chronic Lymphocytic Leukemia

Turk J Haematol. 2024 Mar 1;41(1):57-58. doi: 10.4274/tjh.galenos.2023.2023.0368.

Authors

Ayşe Kaya¹, İbrahim Aras², Pervin Özkan Kurtgöz³, Umut Çakıroğlu⁴

Affiliations

¹ University of Health Sciences Türkiye, Van Training and Research Hospital, Clinic of Hematology, Van, Türkiye.
² Van Yüzüncü Yıl University Faculty of Medicine, Department of Medical Pathology, Van, Türkiye.
³ University of Health Sciences Türkiye, Van Training and Research Hospital, Clinic of Nephrology, Van, Türkiye.
⁴ Van Yüzüncü Yıl University Faculty of Medicine, Department of Medical Oncology, Van, Türkiye.

No abstract available

Keywords: Chronic lymphocytic leukemia; Ibrutinib; Ibrutinib-associated vasculitis; Leukocytoclastic vasculitis.

MeSH terms

Adenine / analogs & derivatives*
Humans
Leukemia, Lymphocytic, Chronic, B-Cell* / complications
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
Piperidines / adverse effects
Vasculitis, Leukocytoclastic, Cutaneous* / chemically induced
Vasculitis, Leukocytoclastic, Cutaneous* / diagnosis

Substances

ibrutinib
Piperidines
Adenine

Supplementary concepts

Erythema elevatum diutinum